Search

everythinglearnresearchcommunity

for

Search:↓

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

The Chinese herbal supplement BeauTop can potentially boost hair growth and thickness by increasing a protein called Vascular Endothelial Growth Factor.

The document concludes that various signaling pathways and genetic factors are crucial for chicken feather development, affecting poultry quality.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

Botryococcus terribilis Ethanol Extract may reduce inflammation by changing gene expression in cells.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Baricitinib is effective for severe alopecia areata but has some side effects.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Plant extracts can help prevent hair loss and promote hair growth.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.